Form 8-K Hims & Hers Health, Inc. For: Jun 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
Hims & Hers units enter $400M receivables deal with JPMorgan
July 1, 2026 5:04 PM EDTSubsidiaries of Hims & Hers Health, Inc. (NYSE: HIMS) entered into a receivables purchase agreement with JPMorgan Chase Bank, N.A. on July 1, 2026, according to a regulatory filing.
XeCare LLC and Apostrophe Pharmacy LLC, both subsidiaries of Hims & Hers, signed a Master Receivables Purchase Agreement that allows them to sell eligible receivables... More
